Risk factor analysis of recurrence in low-grade endometrial adenocarcinoma

被引:32
作者
Roma, Andres A. [1 ]
Rybicki, Lisa A. [2 ]
Barbuto, Denise [3 ]
Euscher, Elizabeth [4 ]
Djordjevic, Bojana [5 ]
Frauenhoffer, Elizabeth [6 ]
Kim, Insun [7 ]
Hong, Sung Ran [8 ]
Montiel, Delia [9 ]
Ali-Fehmi, Rouba [10 ]
Malpica, Anais [4 ]
Silva, Elvio G. [3 ]
机构
[1] Cleveland Clin, Robert J Tomsich Pathol & Lab Med Inst, Dept ofPathol, Cleveland, OH 44195 USA
[2] Lerner Res Inst, Dept Quantitat Hlth Sci, Cleveland, OH USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX USA
[4] Cedars Sinai Med Ctr, Dept Pathol, Los Angeles, CA USA
[5] Univ Ottawa, Dept Pathol, Ottawa, ON K1H 8M5, Canada
[6] Penn State Univ, Dept Pathol & Lab Med, Hershey, PA 17033 USA
[7] Korea Univ, Anam Hosp, Dept Pathol, Seoul 136705, South Korea
[8] Dankook Univ, Cheil Gen Hosp, Dept Pathol, Seoul 100450, South Korea
[9] Inst Nacl Cancerol, Mexico City 14080, DF, Mexico
[10] Wayne State Univ, Dept Pathol, Detroit, MI 48101 USA
关键词
Low-grade; Endometrial adenocarcinoma; Endometrioid; Myometrial invasion; Lymph node metastasis; Recurrence; GYNECOLOGIC-ONCOLOGY-GROUP; MELF PATTERN INVASION; STAGE-I; RANDOMIZED-TRIAL; CANCER; CARCINOMA; SURVIVAL; THERAPY; PREDICTORS; FAILURE;
D O I
10.1016/j.humpath.2015.06.015
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Prognosis of endometrial adenocarcinoma is favorable; however, the risk of recurrence ranges from 7% to 13%. Recurrence has been related to age, tumor type, International Federation of Gynecology and Obstetrics grade, depth of invasion, and lymphovascular invasion (LVI); however, morphologic features that would predict the site of recurrence have not been established. In this multi-institutional study, we reviewed 589 patients with International Federation of Gynecology and Obstetrics grades 1 or 2 endometrial adenocarcinoma, endometrioid type. Cox proportional hazard analysis was used to identify univariate and multivariate risk factors for recurrence and survival. Univariate analysis revealed features of tumors that recurred only in the vagina: low nuclear grade; superficial myoinvasion; minimal to no LVI; and minimal myoinvasion with microcystic, elongated, and fragmented (MELF) pattern; low nuclear grade and superficial myoinvasion persisted on multivariate analysis. Features of tumors that recurred at other sites included large size, deep myoinvasion, tumor necrosis, 1 or more LVI foci, LVI foci distant/deeper than invasive tumor front, MELF myoinvasion pattern, lower uterine segment and cervical stromal involvement, pelvic and/or paraaortic lymph node metastases at presentation, and higher grade of tumor in the metastatic foci, whereas increased percentage of solid component and lower percentage of mucinous features were marginally associated. Tumors with recurrences only in vagina had different features than tumors that recurred at other sites. The presence of tumor necrosis, MELF foci at the invasive tumor front, and the percentage of solid component and mucinous features could be helpful in grading endometrioid adenocarcinomas, if a 2-tier rather than a 3-tier grading system is accepted in the future. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:1529 / 1539
页数:11
相关论文
共 50 条
  • [41] Does ovarian preservation have an effect on recurrence of early stage low-grade endometrial stromal sarcoma?
    Karatasli, Volkan
    Cakir, Ilker
    Can, Behzat
    Erkilinc, Selcuk
    Karadeniz, Tugba
    Kuru, Oguzhan
    Gokcu, Mehmet
    Sanci, Muzaffer
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2021, 41 (05) : 797 - 802
  • [42] Low-grade and high-grade endometrial stromal sarcoma: A National Cancer Database study
    Seagle, Brandon-Luke L.
    Shilpi, Arunima
    Buchanan, Samuel
    Goodman, Chelain
    Shahabi, Shohreh
    GYNECOLOGIC ONCOLOGY, 2017, 146 (02) : 254 - 262
  • [43] Phase 2 Trial of Mifepristone (RU-486) in Advanced or Recurrent Endometrioid Adenocarcinoma or Low-Grade Endometrial Stromal Sarcoma
    Ramondetta, Lois M.
    Johnson, Alaina J.
    Sun, Charlotte C.
    Atkinson, Neely
    Smith, Judith A.
    Jung, Maria S.
    Broaddus, Russel
    Iyer, Revathy B.
    Burke, Thomas
    CANCER, 2009, 115 (09) : 1867 - 1874
  • [44] Cytomorphologic features of low-grade endometrial stromal sarcoma
    Policarpio-Nicolas, Maria Luisa
    Cathro, Helen P.
    Kerr, Sarah E.
    Stelow, Edward B.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2007, 128 (02) : 265 - 271
  • [45] Predicting factors for recurrence in low-grade Ta primary bladder tumours
    Molina Escudero, R.
    Alvarez Ardura, M.
    Ripalda Ferretti, E.
    Crespo Martinez, L.
    Gonzalez Avila, N.
    Dorado Valentin, M.
    Paez Borda, A.
    ARCHIVOS ESPANOLES DE UROLOGIA, 2014, 67 (06): : 541 - 548
  • [46] Recurrence and malignant degeneration after resection of adult hemispheric low-grade gliomas Clinical article
    Chaichana, Kaisorn L.
    McGirt, Matthew J.
    Laterra, John
    Olivi, Alessandro
    Quinones-Hinojosa, Alfredo
    JOURNAL OF NEUROSURGERY, 2010, 112 (01) : 10 - 17
  • [47] Lymphovascular Space Invasion (LVSI) Is an Isolated Poor Prognostic Factor for Recurrence and Survival Among Women With Intermediate- to High-Risk Early-Stage Endometrioid Endometrial Cancer
    Weinberg, Lori E.
    Kunos, Charles A.
    Zanotti, Kristine M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08) : 1438 - 1445
  • [48] Bilateral femur metastases in low-grade endometrial carcinoma
    Lunardi, Pierre
    Vidal, Fabien
    Accadbled, Franck
    Leguevaque, Pierre
    Soule-Tholy, Marc
    Beauval, Jean Baptiste
    Motton, Stephanie
    CLINICAL CASE REPORTS, 2015, 3 (07): : 582 - 586
  • [49] Ovarian preservation for low-grade endometrial stromal sarcoma: a systematic review of the literature and meta-analysis
    Nasioudis, Dimitrios
    Ko, Emily M.
    Kolovos, Georgios
    Vagios, Stylianos
    Kalliouris, Dimitrios
    Giuntoli, Robert L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 (01) : 126 - 132
  • [50] Low-Grade Ovarian Serous Adenocarcinoma with Lymph Node Metastasis in Neck
    Chen, Shih-Lung
    Hsieh, Tsan-Yu
    Yang, Shih-Wei
    DIAGNOSTICS, 2021, 11 (10)